Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Disease, Chronic Obstructive

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease

NCT02238145

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease

NCT02238197

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02238119

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients

NCT02125916

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +6 more
Locations: Department of pulmonology and allergology, Aarhus University Hospital, NBG Aarhus, Denmark

View Trial Details

Completed

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02238106

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT02238184

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02236182

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease

NCT02236715

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02236169

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis

NCT02233920

Conditions: Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations: Not specified

View Trial Details